Mr. Naik serves as CFO of Beacon Pharmaceutical. Prior to assuming his current roles, he founded Reva Capital Markets, an investment bank, in 2009. He is an talented capital markets banker, having spent the majority of his two-decade career working within them. . Before then Vageesh headed sales for structured products at Knight Libertas. Earlier, at the Royal Bank of Scotland. Vageesh was involved in the structuring, banking, and syndication functions for fixed income securities. Where he was responsible for expanding the distribution effort to Asia, Middle East, and Continental Europe. At Ernst & Young’s Structured Finance Advisory Group, he advised issuers, investors, and service providers on esoteric fixed income securities.
At Beacon Pharmaceutical, Vageesh is responsible to continuously assess the capital needs of incubated companies and to provide timely access to funds. As CEO of Reva, he has built extensive relationships with the global life-science investment community. He has excellent relationships with the life-science communities in China and India. He continuously explore partnership opportunities in these geographies with medical industry, investment community as well as other high-profile incubators and universities.
Vageesh is an active investor in startups and small businesses in the US, China, and India. His business interests include, life-sciences, environment, security tokens, real estate, agriculture, and sports.